Clinical characteristics associated with lithium use among adolescents with bipolar disorder

Journal of Child and Adolescent Psychopharmacology

Volumn 24, Issue 7, 2014, Pages 382-389

  Ko, Athena ^a   Swampillai, Brenda ^a   Timmins, Vanessa ^a   Scavone, Antonette ^a   Collinger, Katelyn ^a   Goldstein, Benjamin I ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; LITHIUM; NEUROLEPTIC AGENT; TRANQUILIZER; LITHIUM DERIVATIVE; PSYCHOTROPIC AGENT;

ADOLESCENT; ADULT; ARTICLE; AUTOMUTILATION; BIPOLAR DISORDER; BIPOLAR I DISORDER; BIPOLAR II DISORDER; BIPOLAR NOT OTHERWISE SPECIFIED; CONFUSION; CONTROLLED STUDY; FAMILY CONFLICT; FAMILY HISTORY; FEMALE; HOSPITALIZATION; HUMAN; IDENTITY; IMPULSIVENESS; LIFESPAN; MAJOR CLINICAL STUDY; MALE; MENTAL INSTABILITY; OUTPATIENT DEPARTMENT; SCHEDULE FOR AFFECTIVE DISORDERS AND SCHIZOPHRENIA; SUICIDAL IDEATION; TERTIARY CARE CENTER; CANADA; CLINICAL PRACTICE; COMORBIDITY; MENTAL DISORDERS; PSYCHOLOGICAL RATING SCALE; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; BIPOLAR DISORDER; COMORBIDITY; FEMALE; HUMANS; LITHIUM COMPOUNDS; MALE; MENTAL DISORDERS; ONTARIO; PHYSICIAN'S PRACTICE PATTERNS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTROPIC DRUGS; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84907031189     PISSN: 10445463     EISSN: 15578992     Source Type: Journal    
DOI: 10.1089/cap.2013.0120     Document Type: Article

References (56)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Association; 1994.
2. Axelson D, Birmaher BJ, Brent D, Wassick S, Hoover C, Bridge J, Ryan N: A preliminary study of the Kiddie Schedule for Affective Disorders and Schizophrenia for School-Age Children mania rating scale for children and adolescents. J Child Adolesc Psychopharmacol 13:463-470, 2003.
3. Axelson D, Birmaher BJ, Strober M, Gill MK, Valeri S, Chiappetta L, Ryan N, Leonard H, Hunt J, Iyengar S, Bridge J, Keller M: Phenomenology of children and adolescents with bipolar spectrum disorders. Arch Gen Psychiatry 63:1139-1148, 2006.
4. Baldessarini RJ, Tondo L: Suicide risk and treatments for patients with bipolar disorder. JAMA 290:1517-1519, 2003.
5. Bhagwagar Z, Goodwin GM: Role of mood stabilizers in bipolar disorder. Expert Rev Neurother 2:239-248, 2002.
6. Bhangoo RK, Lowe CH, Myers FS, Treland J, Curran J, Towbin KE, Leibenluft E: Medication use in children and adolescents treated in the community for bipolar disorder. J Child Adolesc Psychopharmacol 13:515-522, 2003.
7. Birmaher B, Axelson D, Strober M, Gill MK, Valeri S, Chiappetta L, Ryan N, Leonard H, Hunt J, Iyengar S, Keller M: Clinical course of children and adolescents with bipolar spectrum disorders. Arch Gen Psychiatry 63:175-183, 2006.
8. Birmaher B, Brent DA, Kolko D, Baugher M, Bridge J, Holder D, Iyengar S, Ulloa RE: Clinical outcome after short-term psychotherapy for adolescents with major depressive disorder. Arch Gen Psychiatry 57:29-36, 2000.
9. Chambers WJ, Puig-Antich J, Hirsch M, Paez P, Ambrosini PJ, Tabrizi MA, Davies M: The assessment of affective disorders in children and adolescents by semistructured interview: Test-retest reliability of the Schedule for Affective Disorders and Schizophrenia for School-Age Children, Present Episode Version. Arch Gen Psychiatry 42:696-702, 1985.
10. Chang K, Karchemskiy A, Barnea-Goraly N, Garrett A, Simeonova DI, Reiss A: Reduced amygdalar gray matter volume in familial pediatric bipolar disorder. J Am Acad Child Adolesc Psychiatry 44:565-573, 2005.
11. Collins JC, McFarland BH: Divalproex, lithium and suicide among Medicaid patients with bipolar disorder. J Affect Disord 107:23-28, 2008.
12. Consoli A, Brunelle J, Bodeau N, Périsse D, Deniau E, Guilé JM, Cohen D: Medication use in adolescents treated in a French psychiatric setting for acute manic or mixed episode. J Can Acad Child Adolesc Psychiatry 18:231-238, 2009.
13. Correll CU, Sheridan EM, DelBello MP: Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: A comparative analysis of acute, randomized, placebo-controlled trials. Bipolar Disord 12:116-141, 2010.
14. DelBello MP, Correll CU, Carlson GA, Carlson HE, Kratochvil CJ: Pharmacological management of bipolar disorder in a youth with diabetes. J Am Acad Child Adolesc Psychiatry 46:1375-1379, 2007.
15. Depp C, Ojeda VD, Mastin W, Unützer J, Gilmer TP: Trends in use of antipsychotics and mood stabilizers among Medicaid beneficiaries with bipolar disorder, 2001-2004. Psychiatr Serv 59:1169-1174, 2008.
16. Duffy A: Does bipolar disorder exist in children? A selected review. Can J Psychiatry 52:409-417, 2007.
17. Dunner DL: Correlates of suicidal behavior and lithium treatment in bipolar disorder. J Clin Psychiatry 65 Suppl 10:5-10, 2004.
18. Findling RL, Frazier JA, Kafantaris V, Kowatch R, McClellan J, Pavuluri M, Sikich L, Hlastala S, Hooper SR, Demeter CA, Bedoya D, Bronwstein B, Taylor-Zapata P: The Collaborative Lithium Trials (CoLT): Specific aims, methods, and implementation. Child Adolesc Psychiatry Ment Health 2:21, 2008.
19. Findling RL, Kafantaris V, Pavuluri M, McNamara NK, McClellan J, Frazier JA, Sikich L, Kowatch R, Lingler J, Faber J, Rowles BM, Clemons TE, Taylor-Zapata P: Dosing strategies for lithium monotherapy in children and adolescents with bipolar I disorder. J Child Adolesc Psychopharmacol 21:195-205, 2011.
20. Findling RL, Landersdorfer CB, Kafantaris V, Pavuluri M, McNamara NK, McClellan J, Frazier JA, Sikich L, Kowatch R, Lingler J, Faber J, Taylor-Zapata P, Jusko WJ: First-dose pharmacokinetics of lithium carbonate in children and adolescents. J Clin Psychopharmacol 30:404-410, 2010.
21. Findling RL, McNamara NK, Youngstrom EA, Stansbrey R, Gracious BL, Reed MD, Calabrese JR: Double-blind 18-month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. J Am Acad Child Adolesc Psychiatry 44:409-417, 2005.
22. Frangou S, Raymont V, Bettany D: The Maudsley bipolar disorder project: A survey of psychotropic prescribing patterns in bipolar I disorder. Bipolar Disord 4:378-385, 2002.
23. Geller B, Cooper TB, Sun K, Zimerman B, Frazier J, Williams M, Heath J: Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. J Am Acad Child Adolesc Psychiatry 37:171-178, 1998.
24. Geller B, Luby JL, Joshi P, Wagner KD, Emslie G, Walkup JT, Axelson DA, Bolhofner K, Robb A, Wolf DV, Riddle MA, Birmaher B, Nusrat N, Ryan ND, Vitiello B, Tillman R, Lavori P: A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents. Arch Gen Psychiatry 69:515-528, 2012.
25. Geller B, Tillman R, Bolhofner K, Zimerman B: Pharmacological and non-drug treatment of child bipolar I disorder during prospective eight-year follow-up. Bipolar Disord 12:164-171, 2010.
26. Gerson AC, Gerring JP, Freund L, Joshi PT, Capozzoli J, Brady K, Denckla MB: The Children's Affective Lability Scale: A psychometric evaluation of reliability. Psychiatry Res 65:189-198, 1996.
27. Ghaemi SN, Hsu DJ, Thase ME, Wisniewski SR, Nierenberg AA, Miyahara S, Sachs G: Pharmacological treatment patterns at study entry for the first 500 STEP-BD participants. Psychiatr Serv 57:660-665, 2006.
28. Goldberg JF, Allen MH, Miklowitz DA, Bowden CL, Endick CJ, Chessick CA, Wisniewski SR, Miyahara S, Sagduyu K, Thase ME, Calabrese JR, Sachs GS: Suicidal ideation and pharmacotherapy among STEP-BD patients. Psychiatric Serv 56:1534-1540, 2005.
29. Goldstein BI, Sassi R, Diler RS: Pharmacologic treatment of bipolar disorder in children and adolescents. Child Adolesc Psychiatr Clin N Am 21:911-939, 2012.
30. Goldstein BI, Strober M, Axelson D, Goldstein TR, Gill MK, Hower H, Dickstein D, Hunt J, Yen S, Kim E, Ha W, Liao F, Fan J, Iyengar S, Ryan ND, Keller MB, Birmaher B: Predictors of firstonset substance use disorders during the prospective course of bipolar spectrum disorders in adolescents. J Am Acad Child Adolesc Psychiatry 52:1026-1037, 2013.
31. Goodwin FK, Fireman B, Simon GE, Hunkeler EM, Lee J, Revicki D: Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA 11:1467-1473, 2003.
32. Grof P, Duffy A, Alda M, Hajek T: Lithium response across generations. Acta Psychiatr Scand 120:378-385, 2009.
33. Halcomb ME, Gould TD, Grahame NJ: Lithium, but not valproate, reduces impulsive choice in the delay-discounting task in mice. Neuropsychopharmacology 38:1937-1944, 2013.
34. Haupt DW, Rosenblatt LC, Kim E, Baker RA, Whitehead R, Newcomer JW: Prevalence and predictors of lipid and glucose monitoring in commercially insured patients treated with second-generation antipsychotic agents. Am J Psychiatry 166:345-353, 2009.
35. Hollander E, Pallanti S, Allen A, Sood E, Baldini Rossi N: Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders? Am J Psychiatry 162:137-145, 2005.
36. Kafantaris V, Coletti D, Dicker R, Padula G, Kane JM: Lithium treatment of acute mania in adolescents: A large open trial. J Am Acad Child Adolesc Psychiatry 42:1038-1045, 2003.
37. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N: Schedule for Affective Disorders and Schizophrenia for School-Age Children - Present and Lifetime Version (K-SADS-PL): Initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36:980-988, 1997.
38. Kilbourne AM, Pincus HA: Patterns of psychotropic medication use by race among veterans with bipolar disorder. Psychiatr Serv 57:123-126, 2006.
39. Kowatch RA, Fristad M, Birmaher B, Wagner KD, Findling RL, Hellander M: Treatment guidelines for children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 44:213-235, 2005.
40. Liu HY, Potter MP, Woodworth KY, Yorks DM, Petty CR, Wozniak JR, Faraone SV, Biederman J: Pharmacological treatments for pediatric bipolar disorder: A review and meta-analysis. J Am Acad Child Adolesc Psychiatry 50:749-762, 2011.
41. Masi G, Perugi G, Millepiedi S, Mucci M, Pfanner C, Berloffa S, Pari C, Gagliano A, D'Amico F, Akiskal HS: Pharmacological response in juvenile bipolar disorder subtypes: A naturalistic retrospective examination. Psychiatry Res 177:192-198, 2010.
42. Morrato EH, Nicol GE, Maahs D, Druss BG, Hartung DM, Valuck RJ, Campagna E, Newcomer JW: Metabolic screening in children receiving antipsychotic drug treatment. Arch Pediatr Adolesc Med 164:344-351, 2010.
43. Ohmura Y, Tsutsui-Kimura I, Kumamoto H, Minami M, Izumi T, Yamaguchi T, Yoshida T, Yoshioka M: Lithium, but not valproic acid or carbamazepine, suppresses impulsive-like action in rats. Psychopharmacology 219:421-432, 2012.
44. Patel NC, DelBello MP, Bryan HS, Adler CM, Kowatch RA, Stanford K, Strakowski SM: Open-label lithium for the treatment of adolescents with bipolar depression. J Am Acad Child Adolesc Psychiatry 45:289-297, 2006a.
45. Patel NC, DelBello MP, Cecil KM, Adler CM, Bryan HS, Stanford KE, Strakowski SM: Lithium treatment effects on myo-inositol in adolescents with bipolar depression. Biol Psychiatry 60:998-1004, 2006b.
46. Patel NC, DelBello MP, Cecil KM, Stanford KE, Adler CM, Strakowski SM: Temporal change in N-acetyl-aspartate concentrations in adolescents with bipolar depression treated with lithium. J Child Adolesc Psychopharmacol 18:132-139, 2008.
47. Patten SB, Waheed W, Bresee L: A review of pharmacoepidemiologic studies of antipsychotic use in children and adolescents. Can J Psychiatry 57:717-721, 2012.
48. Pfeifer JC, Kowatch RA, DelBello MP: Pharmacotherapy of bipolar disorder in children and adolescents. CNS Drugs 24:576-593, 2010.
49. Potter MP, Liu HY, Monuteaux MC, Henderson CS, Wozniak J, Wilens TE, Biederman J: Prescribing patterns for treatment of pediatric bipolar disorder in a specialty clinic. J Child Adolesc Psychopharmacol 19:529-538, 2009.
50. Robin AL, Foster SL: Negotiating Parent-Adolescent Conflict: A Behavioural Family Systems Approach. New York: Guilford Press; 1989.
51. Shaffer D, Gould MS, Brasic J, Ambrosini P, Fisher P, Bird H, Aluwahlia S: A Children's Global Assessment Scale (CGAS). Arch Gen Psychiatry 40:1228-1231, 1983.
52. Singh JB, Zarate CA: Pharmacological treatment of psychiatric comorbidity in bipolar disorder: A review of controlled trials. Bipolar Disord 8:696-709, 2006.
53. Strober M, Morrell W, Lampert C, Burroughs J: Relapse following discontinuation of lithiummaintenance therapy in adolescents with bipolar I illness: A naturalistic study. Am J Psychiatry 147:457-461, 1990.
54. Svestka J, Nahumek K: The result of lithium therapy in acute phases of affective psychoses and some other prognostical factors of lithium prophylaxis. Act Nerv Super 17:270-271, 1975.
55. Vitiello B, Riddle MA, Yenokyan G, Axelson DA, Wagner KD, Joshi P, Walkup JT, Luby J, Birmaher B, Ryan ND, Emslie G, Robb A, Tillman R: Treatment moderators and predictors of outcome in the Treatment of Early Age Mania (TEAM) study. J Am Acad Child Adolesc Psychiatry 51:867-878, 2012.
56. Weissman MM, Wickramaratne P, Adams P, Wolk S, Verdeli H, Olfson M: Brief screening for family psychiatric history: The family history screen. Arch Gen Psychiatry 57:675-682, 2000.